Lundbeck
HLUN-B.CO
#2670
Rank
NZ$11.18 B
Marketcap
NZ$11.27
Share price
-1.12%
Change (1 day)
40.02%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): NZ$1.31 Billion

According to Lundbeck's latest financial reports the company's current earnings are NZ$3.80 Billion. , an increase over its 2024 earnings that were of NZ$0.93 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 NZ$1.29 B38.47%
2024 NZ$0.93 B25.74%
2023 NZ$0.74 B21.77%
2022 NZ$0.61 B31.57%
2021 NZ$0.46 B-4.61%
2020 NZ$0.48 B-45.06%
2019 NZ$0.88 B-34.04%
2018 NZ$1.34 B12.83%
2017 NZ$1.19 B93.99%
2016 NZ$0.61 B-137.28%
2015 -NZ$1.66 Billion-1246.24%
2014 NZ$0.14 B-72.36%
2013 NZ$0.52 B4.38%
2012 NZ$0.49 B-55.18%
2011 NZ$1.11 B5.65%
2010 NZ$1.05 B-5.9%
2009 NZ$1.12 B